Advanced search
Publication Cover
Nanomedicine Volume 9, 2014 - Issue 6
Submit an article Journal homepage
583
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Polyethyleneimine-Functionalized Iron Oxide Nanoparticles for Systemic siRNA Delivery in Experimental Arthritis

Juanli Duan1 Key Laboratory of Ministry of Education for Developmental Genes & Human Diseases, School of Life Sciences, Southeast University, Nanjing, ChinaView further author information
,
Jinlai Dong2 State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials & Devices, School of Biological Science & Medical Engineering, Southeast University, Nanjing, ChinaView further author information
,
Tiantian Zhang1 Key Laboratory of Ministry of Education for Developmental Genes & Human Diseases, School of Life Sciences, Southeast University, Nanjing, ChinaView further author information
,
Zhenyi Su3 Department of Biochemistry, School of Medicine, Southeast University, Nanjing, ChinaView further author information
,
Jie Ding3 Department of Biochemistry, School of Medicine, Southeast University, Nanjing, ChinaView further author information
,
Yu Zhang2 State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials & Devices, School of Biological Science & Medical Engineering, Southeast University, Nanjing, ChinaView further author information
&
Xiaohua Mao1 Key Laboratory of Ministry of Education for Developmental Genes & Human Diseases, School of Life Sciences, Southeast University, Nanjing, China;3 Department of Biochemistry, School of Medicine, Southeast University, Nanjing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 789-801 | Received 01 Nov 2013, Published online: 01 Jul 2014

References

  • Kopf M , BachmannMF, MarslandBJ. Averting inflammation by targeting the cytokine environment. Nat. Rev. Drug Discov.9(9), 703–718 (2010).
  • Buch MH , EmeryP. New therapies in the management of rheumatoid arthritis. Curr. Opin. Rheumatol.23(3), 245–251 (2011).
  • Upchurch KS , KayJ. Evolution of treatment for rheumatoid arthritis. Rheumatology51(Suppl. 6), vi28–vi36 (2012).
  • Scott D . Biologics-based therapy for the treatment of rheumatoid arthritis. Clin. Pharmacol. Ther.91(1), 30–43 (2011).
  • Liu G , XieJ, ZhangFet al.: N-alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery. Small7(19), 2742–2749 (2011).
  • Zhang H , Lee M-Y, Hogg MG, Dordick JS, Sharfstein ST. Gene delivery in three-dimensional cell cultures by superparamagnetic nanoparticles. ACS Nano4(8), 4733–4743 (2010).
  • Szekanecz Z , KochAE. Vascular involvement in rheumatic diseases:‘vascular rheumatology‘. Arthritis Res. Ther.10(5), 224 (2008).
  • Kinne RW , StuhlmüllerB, Burmester G-R. Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res. Ther.9(6), 224 (2007).
  • Szekanecz Z , KochAE. Macrophages and their products in rheumatoid arthritis. Curr. Opin. Rheumatol.19(3), 289–295 (2007).
  • Brennan FM , McinnesIB. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest.118(11), 3537 (2008).
  • Mcinnes IB , GracieJA. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr. Opin. Pharmacol.4(4), 392–397 (2004).
  • Zhang T , BaiX, MaoX. Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis. PLoS ONE8(11), e78619 (2013).
  • Wang CY , HongJM, ChenG, ZhangY, GuN. Facile method to synthesize oleic acid-capped magnetite nanoparticles. Chinese Chem. Lett.21(2), 179–182 (2010).
  • Wu Y , SongM, XinZet al. Ultra-small particles of iron oxide as peroxidase for immunohistochemical detection. Nanotechnology 22(22), 225703 (2011).
  • Wang D , DengX, LengX, MaoX. Interleukin-15 receptor-directed immunotoxins atteunuate disease severity in rat adjuvant arthritis. Mol. Immunol.47(7), 1535–1543 (2010).
  • Cole AJ , DavidAE, WangJ, GalbánCJ, YangVC. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials32(26), 6291–6301 (2011).
  • Xia T , KovochichM, LiongMet al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3(10), 3273–3286 (2009).
  • Courties G , SeiffartV, PresumeyJet al.: In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells. Blood116(18), 3505–3516 (2010).
  • Mitragotri S , Yoo J-W. Designing micro- and nano-particles for treating rheumatoid arthritis. Arch. Pharm. Res.34(11), 1887–1897 (2011).
  • Khaja FA , KooO, OnyukselH. Nanomedicines for inflammatory diseases. Methods Enzymol.508, 355–375 (2012).
  • Butoescu N , SeemayerCA, FotiM, JordanO, DoelkerE. Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials30(9), 1772–1780 (2009).
  • Butoescu N , SeemayerC, PalmerGet al. Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice. Arthritis Res. Ther. 11(3), R72 (2009).
  • Scheinman RI , TrivediR, VermillionS, KompellaUB. Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model. Nanomedicine (Lond.)6(10), 1669–1682 (2011).
  • Khoury M , Louis-PlenceP, EscriouVet al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor α in experimental arthritis. Arthritis Rheum. 54(6), 1867–1877 (2006).
  • Khoury M , EscriouV, CourtiesGet al. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes. Arthritis Rheum. 58(8), 2356–2367 (2008).
  • Apparailly F , JorgensenC. siRNA-based therapeutic approaches for rheumatic diseases. Nat. Rev. Rheumatol.9(1), 56–62 (2013).
  • Fehniger TA , CaligiuriMA. Interleukin 15: biology and relevance to human disease. Blood97(1), 14–32 (2001).
  • Kurreeman F , DahaN, ChangMet al. Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population. Ann. Rheum. Dis. 68(11), 1789–1790 (2009).
  • Kuuliala A , NissinenR, KautiainenH, RepoH, Leirisalo-RepoM. Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab. Ann. Rheum. Dis.65(1), 26–29 (2006).
  • Mcinnes IB , LeungBP, SturrockRD, FieldM, LiewFY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat. Med.3(2), 189–195 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.